83 FR 37508 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Federal Register Volume 83, Issue 148 (August 1, 2018)
Substance Abuse and Mental Health Services Administration
Federal Register Volume 83, Issue 148 (August 1, 2018)
| Page Range | 37508-37509 | |
| FR Document | 2018-16440 |
[Federal Register Volume 83, Number 148 (Wednesday, August 1, 2018)] [Notices] [Pages 37508-37509] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-16440] [[Page 37508]] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at http://www.samhsa.gov/workplace. FOR FURTHER INFORMATION CONTACT: Charles LoDico, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N02C, Rockville, Maryland 20857; 240-276-2600 (voice). SUPPLEMENTARY INFORMATION: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); April 30, 2010 (75 FR 22809); and on January 23, 2017 (82 FR 7920). The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503 of Public Law 100-71. The ``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' as amended in the revisions listed above, requires strict standards that laboratories and IITFs must meet in order to conduct drug and specimen validity tests on urine specimens for federal agencies. To become certified, an applicant laboratory or IITF must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory or IITF must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. Laboratories and IITFs in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), which attests that it has met minimum standards. In accordance with the Mandatory Guidelines dated January 23, 2017 (82 FR 7920), the following HHS-certified laboratories and IITFs meet the minimum standards to conduct drug and specimen validity tests on urine specimens: HHS-Certified Instrumented Initial Testing Facilities Dynacare, 6628 50th Street NW, Edmonton, AB Canada T6B 2N7, 780-784- 1190, (Formerly: Gamma-Dynacare Medical Laboratories). HHS-Certified Laboratories ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 844-486-9226. Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361- 8989/800-433-3823, (Formerly: Kroll Laboratory Specialists, Inc., Laboratory Specialists, Inc.). Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 804-378-9130, (Formerly: Kroll Laboratory Specialists, Inc., Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.). Baptist Medical Center-Toxicology Laboratory, 11401 I-30, Little Rock, AR 72209-7056, 501-202-2783, (Formerly: Forensic Toxicology Laboratory Baptist Medical Center). Clinical Reference Laboratory, Inc., 8433 Quivira Road, Lenexa, KS, 66215-2802, 800-445-6917. DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800- 235-4890. Dynacare*, 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679- 1630, (Formerly: Gamma-Dynacare Medical Laboratories). ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 662-236-2609. Laboratory Corporation of America Holdings, 7207 N Gessner Road, Houston, TX 77040, 713-856-8288/800-800-2387. Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869, 908-526-2400/800-437-4986, (Formerly: Roche Biomedical Laboratories, Inc.). Laboratory Corporation of America Holdings, 1904 TW Alexander Drive, Research Triangle Park, NC 27709, 919-572-6900/800-833-3984, (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group). Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671, 866-827-8042/800-233-6339, (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center). LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219, 913-888-3927/800-873-8845, (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.). MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 651-636-7466/800-832-3244. Legacy Laboratory Services--MetroLab, 1225 NE 2nd Ave., Portland, OR 97232, 503-413-5295/800-950-5295. Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088. Testing for Veterans Affairs (VA) Employees Only. National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304, 661-322-4250/800-350-3515. One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, TX 77504, 888-747-3774, (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory). Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311, 800-328-6942, (Formerly: Centinela Hospital Airport Toxicology Laboratory). Pathology Associates Medical Laboratories, 110 West Cliff Dr., [[Page 37509]] Spokane, WA 99204, 509-755-8991/800-541-7891x7. Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635- 5840. Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 800-729-6432, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 610-631-4600/877-642-2216, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Redwood Toxicology Laboratory, 3700 Westwind Blvd., Santa Rosa, CA 95403, 800-255-2159. STERLING Reference Laboratories, 2617 East L Street, Tacoma, WA 98421, 800-442-0438. US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755-5235, 301-677-7085, Testing for Department of Defense (DoD) Employees Only. * The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on January 23, 2017 (82 FR 7920). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Charles P. LoDico, Chemist. [FR Doc. 2018-16440 Filed 7-31-18; 8:45 am] BILLING CODE 4160-20-P
![Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 37509
Spokane, WA 99204, 509–755–8991/ DEPARTMENT OF HOMELAND fees, barges and other bulk carriers
800–541–7891x7. SECURITY arrival fees, and merchandise processing
Phamatech, Inc., 15175 Innovation fees, as well as the corresponding
Drive, San Diego, CA 92128, 888– U.S. Customs and Border Protection limitations.
635–5840. [CBP Dec. 18–08] Determination of Whether an
Quest Diagnostics Incorporated, 1777 Adjustment Is Necessary for Fiscal Year
Montreal Circle, Tucker, GA 30084, COBRA Fees To Be Adjusted for 2019
800–729–6432, (Formerly: SmithKline Inflation in Fiscal Year 2019
Beecham Clinical Laboratories; In accordance with 19 CFR 24.22, CBP
SmithKline Bio-Science Laboratories). AGENCY: U.S. Customs and Border must determine annually whether the
Quest Diagnostics Incorporated, 400 Protection, Department of Homeland fees and limitations must be adjusted to
Egypt Road, Norristown, PA 19403, Security. reflect inflation. For fiscal year 2019,
610–631–4600/877–642–2216, ACTION: General notice. CBP is making this determination by
(Formerly: SmithKline Beecham comparing the average of the Consumer
SUMMARY: This document announces Price Index—All Urban Consumers, U.S.
Clinical Laboratories; SmithKline Bio- that U.S. Customs and Border Protection
Science Laboratories). All items, 1982–84 (CPI–U) for the
(CBP) is adjusting certain customs user current year (June 2017–May 2018) with
Redwood Toxicology Laboratory, 3700 fees and limitations established by the the average of the CPI–U for the
Westwind Blvd., Santa Rosa, CA Consolidated Omnibus Budget comparison year (June 2016-May 2017)
95403, 800–255–2159. Reconciliation Act (COBRA) for Fiscal to determine the change in inflation, if
STERLING Reference Laboratories, 2617 Year 2019 in accordance with the Fixing any. If there is an increase in the CPI of
East L Street, Tacoma, WA 98421, America’s Surface Transportation Act greater than one (1) percent, CBP must
800–442–0438. (FAST Act) as implemented by CBP adjust the customs COBRA user fees and
US Army Forensic Toxicology Drug regulations. corresponding limitations using the
Testing Laboratory, 2490 Wilson St., methodology set forth in 19 CFR
Fort George G. Meade, MD 20755– DATES: The adjusted amounts of
customs COBRA user fees and their 24.22(k). (19 CFR 24.22(k)). Following
5235, 301–677–7085, Testing for the steps provided in paragraph (k)(2) of
Department of Defense (DoD) corresponding limitations set forth in
this notice for Fiscal Year 2019 are section 24.22, CBP has determined that
Employees Only. the increase in the CPI between the most
required as of October 1, 2018.
* The Standards Council of Canada recent June to May 12-month period
(SCC) voted to end its Laboratory FOR FURTHER INFORMATION CONTACT: Tina
(June 2017–May 2018) and the
Accreditation Program for Substance Ghiladi, Director—Office of Finance,
comparison year (June 2016-May 2017)
Abuse (LAPSA) effective May 12, 1998. 202–344–3722, UserFeeNotices@
is 2.063 1 percent. As the increase in the
Laboratories certified through that cbp.dhs.gov.
CPI is greater than one (1) percent, the
program were accredited to conduct SUPPLEMENTARY INFORMATION: customs COBRA user fees and
forensic urine drug testing as required corresponding limitations must be
Background
by U.S. Department of Transportation adjusted for Fiscal Year 2019.
(DOT) regulations. As of that date, the On December 4, 2015, the Fixing
certification of those accredited America’s Surface Transportation Act Determination of the Adjusted Fees and
Canadian laboratories will continue (FAST Act, Pub. L. 114–94) was signed Limitations
under DOT authority. The responsibility into law. Section 32201 of the FAST Act Using the methodology set forth in
for conducting quarterly performance amended section 13031 of the section 24.22(k)(2) of the CBP
testing plus periodic on-site inspections Consolidated Omnibus Budget regulations (19 CFR 24.22(k)), CBP has
of those LAPSA-accredited laboratories Reconciliation Act (COBRA) of 1985 (19 determined that the factor by which the
was transferred to the U.S. HHS, with U.S.C. 58c) by requiring certain customs base fees and limitations will be
the HHS’ NLCP contractor continuing to COBRA user fees and corresponding adjusted is 4.866 percent (base fees and
have an active role in the performance limitations to be adjusted by the limitations can be found in Appendix A
testing and laboratory inspection Secretary of the Treasury (Secretary) to and B to part 24 of title 19). In reaching
processes. Other Canadian laboratories reflect certain increases in inflation. this determination, CBP calculated the
wishing to be considered for the NLCP Sections 24.22 and 24.23 of title 19 of values for each variable found in
may apply directly to the NLCP the Code of Federal Regulations (19 CFR paragraph (k) of 19 CFR 24.22 as
contractor just as U.S. laboratories do. 24.22 and 24.23) describe the follows:
Upon finding a Canadian laboratory to procedures that implement the • The arithmetic average of the CPI–
be qualified, HHS will recommend that requirements of the FAST Act. U for June 2017–May 2018, referred to
DOT certify the laboratory (Federal Specifically, paragraph (k) in section as (A) in the CBP regulations, is
Register, July 16, 1996) as meeting the 24.22 (19 CFR 24.22(k)) sets forth the 247.540;
minimum standards of the Mandatory methodology to determine the change in • The arithmetic average of the CPI–
Guidelines published in the Federal inflation as well as the factor by which U for Fiscal Year 2014, referred to as (B),
Register on January 23, 2017 (82 FR the fees and limitations will be adjusted, is 236.009;
7920). After receiving DOT certification, if necessary. The fees and limitations • The arithmetic average of the CPI–
the laboratory will be included in the subject to adjustment, which are set U for the comparison year, referred to as
forth in Appendix A and Appendix B of (C), is 242.328;
sradovich on DSK3GMQ082PROD with NOTICES
monthly list of HHS-certified
laboratories and participate in the NLCP part 24, include the commercial vessel • The difference between the
certification maintenance program. arrival fees, commercial truck arrival arithmetic averages of the CPI–U of the
fees, railroad car arrival fees, private
Charles P. LoDico, vessel arrival fees, private aircraft 1 The figures provided in this notice may be
Chemist. rounded for publication purposes only. The
arrival fees, commercial aircraft and calculations for the adjusted fees and limitations
[FR Doc. 2018–16440 Filed 7–31–18; 8:45 am] vessel passenger arrival fees, dutiable were made using unrounded figures, unless
BILLING CODE 4160–20–P mail fees, customs broker permit user otherwise noted.
VerDate Sep<11>2014 20:07 Jul 31, 2018 Jkt 244001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\01AUN1.SGM 01AUN1](https://thefederalregister.org/doc/83_FR_37656/page/2.svg)
Document Created: 2018-08-01 01:22:54
Document Modified: 2018-08-01 01:22:54
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Charles LoDico, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N02C, Rockville, Maryland 20857; 240-276-2600 (voice). | |
| FR Citation | 83 FR 37508 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR